Biblio

Found 61 results
Author Keyword [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
F. R. Sattler, He, J., Letendre, S., Wilson, C., Sanders, C., Heaton, R., Ellis, R., Franklin, D., Aldrovandi, G., Marra, C. M., Clifford, D., Morgello, S., Grant, I., and J McCutchan, A., Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation., J Acquir Immune Defic Syndr, vol. 68, no. 3, pp. 281-8, 2015.
D. B. Clifford, Vaida, F., Kao, Y. - T., Franklin, D. R., Letendre, S. L., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Grant, I., and Heaton, R. K., Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people., Neurology, vol. 84, no. 3, pp. 241-50, 2015.
E. E. Morgan, Woods, S. P., Letendre, S. L., Franklin, D. R., Bloss, C., Goate, A., Heaton, R. K., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Ellis, R. J., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D. M., Grant, I., Vaida, F., and Clifford, D. B., Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders., J Neurovirol, vol. 19, no. 2, pp. 150-6, 2013.
J. Robinson-Papp, Morgello, S., Vaida, F., Fitzsimons, C., Simpson, D. M., Elliott, K. J., Al-Lozi, M., Gelman, B. B., Clifford, D., Marra, C. M., McCutchan, J. A., Atkinson, J. H., Dworkin, R. H., Grant, I., and Ellis, R., Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy., Pain, vol. 151, no. 3, pp. 732-6, 2010.
I. Grant, Franklin, D. R., Deutsch, R., Woods, S. P., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Smith, D. M., and Heaton, R. K., Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline., Neurology, vol. 82, no. 23, pp. 2055-62, 2014.
C
R. J. Ellis, Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Morgello, S., J McCutchan, A., and Grant, I., CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy., AIDS, vol. 25, no. 14, pp. 1747-51, 2011.
E. R. Hammond, Crum, R. M., Treisman, G. J., Mehta, S. H., Marra, C. M., Clifford, D. B., Morgello, S., Simpson, D. M., Gelman, B. B., Ellis, R. J., Grant, I., Letendre, S. L., and McArthur, J. C., The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV., Am J Epidemiol, vol. 180, no. 3, pp. 297-307, 2014.
B. Biswas, Spitznagel, E., Collier, A. C., Gelman, B. B., McArthur, J. C., Morgello, S., McCutchan, J. A., and Clifford, D. B., Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort., J HIV AIDS Soc Serv, vol. 13, no. 1, pp. 8-25, 2014.
T. L. Jernigan, Archibald, S. L., Fennema-Notestine, C., Taylor, M. J., Theilmann, R. J., Julaton, M. D., Notestine, R. J., Wolfson, T., Letendre, S. L., Ellis, R. J., Heaton, R. K., Gamst, A. C., Franklin, D. R., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C., McArthur, J. C., J McCutchan, A., Morgello, S., Simpson, D. M., and Grant, I., Clinical factors related to brain structure in HIV: the CHARTER study., J Neurovirol, vol. 17, no. 3, pp. 248-57, 2011.
A. R. Bharti, Letendre, S. L., Wolfson, T., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Marra, C., McCutchan, A., Morgello, S., Simpson, D., Ellis, R. J., and Grant, I., Clinical variables identify seronegative HCV co-infection in HIV-infected individuals., J Clin Virol, vol. 52, no. 4, pp. 328-32, 2011.
I. Perez-Valero, Cysique, L., Letendre, S., and Heaton, R., Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy"., HIV Clin Trials, vol. 13, no. 5, pp. 296-8; author reply 299-300, 2012.
M. Ferrara, Umlauf, A., Sanders, C., Meyer, J. M., McCutchan, J. Allen, Duarte, N., Atkinson, J. Hampton, Grant, I., and Ellis, R. J., The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk., Psychiatry Res, vol. 218, no. 1-2, pp. 201-8, 2014.
M. Sakamoto, Marcotte, T. D., Umlauf, A., Franklin, D., Heaton, R. K., Ellis, R. J., Letendre, S., Alexander, T., McCutchan, J. A., Morgan, E. E., Woods, S. P., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D., and Grant, I., Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort., J Acquir Immune Defic Syndr, vol. 62, no. 1, pp. 36-42, 2013.
R. J. Ellis, Rosario, D., Clifford, D. B., McArthur, J. C., Simpson, D., Alexander, T., Gelman, B. B., Vaida, F., Collier, A., Marra, C. M., Ances, B., J Atkinson, H., Dworkin, R. H., Morgello, S., and Grant, I., Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study., Arch Neurol, vol. 67, no. 5, pp. 552-8, 2010.
A. M. Anderson, Fennema-Notestine, C., Umlauf, A., Taylor, M. J., Clifford, D. B., Marra, C. M., Collier, A. C., Gelman, B. B., McArthur, J. C., J McCutchan, A., Simpson, D. M., Morgello, S., Grant, I., and Letendre, S. L., CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease., J Neurovirol, vol. 21, no. 5, pp. 559-67, 2015.

Pages